Virus News and Research

Latest Virus News and Research

A high-throughput pipeline for identifying nanobodies that target and neutralize SARS-CoV-2

Researchers in the United States have developed a cost-effective, high-throughput pipeline for identifying effective nanobodies that target and neutralize severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

26 Oct 2021

Extending COVID-19 vaccinations to adolescents and children may lower the overall disease burden

A recent study by researchers from the Netherlands highlights that the introduction of vaccination programs against coronavirus disease 2019 (COVID-19) to adolescents and children may reduce infection rates and severe disease outcomes – both in these age groups and in the population as a whole. The paper is currently available on medRxiv* preprint server while it undergoes peer review.

26 Oct 2021

HCV treatment decreases protein activity levels involved in liver cirrhosis, research shows

Researchers at the Medical University of South Carolina report in the Journal of Viral Hepatitis that the activity levels of the proteins involved in liver scarring, or cirrhosis, begin to decrease immediately after treatment for the hepatitis C virus (HCV), suggesting the possibility of early healing.

26 Oct 2021

Hyperimmune antibody produced in horses may be an efficient approach to combat covid-19

A study conducted by a consortium of Brazilian researchers has demonstrated that a hyperimmune serum consisting of purified antibody fragments produced in horses may be an efficient approach to combat covid-19.

26 Oct 2021

Model suggests longer protection from SARS-CoV-2 neutralizing antibody response

A new study discusses the durability of the immune response following natural infection or vaccination.

26 Oct 2021

Effectiveness of mRNA BNT162b2 COVID-19 vaccine in immunocompromised individuals

Israeli researchers evaluate the antibody response in ICPs to assess antibody-mediated immunity following vaccination with the Pfizer-BioNTech vaccine.

26 Oct 2021

UQ researchers find that SARS-CoV-2 virus does not infect blood vessels

The SARS-CoV-2 virus does not infect blood vessels, despite the high risk of blood clots to COVID-19 patients, University of Queensland researchers have found.

26 Oct 2021

Attitudes towards COVID-19 vaccination amongst essential workers

A new study has addressed these gaps in knowledge regarding the uptake of COVID-19 vaccines among essential workers.

26 Oct 2021

Evaluation of COVID-19 infection risk during US spring semester in-person teaching

The main objective of the study was to determine the rates of in-person schooling and understand the school-based mitigation measures that were modified over the semester.

26 Oct 2021

Identification of long COVID patients using big data

A new preprint exploits big data to come up with some answers as to the incidence, treatment, and impact on healthcare systems of long covid.

26 Oct 2021

High and increasing SARS-CoV-2 infection prevalence amongst school-aged children in England

The latest round of the REACT-1 study indicates SARS-CoV-2 continues to spread among children.

26 Oct 2021

Sexually dimorphic placental antibody transfer during SARS-CoV-2 infection

In a paper recently published in the journal Science Translational Medicine by Bordt et al. (October 19th, 2021), maternal SARS-CoV-2 infections are studied with particular regard to maternal-fetal antibody transfer and virus-induced placental interferon responses, finding a sexually dimorphic response that results in lesser antibody transfer to the male fetus.

26 Oct 2021

Water and surface surveillance can detect 93% of school-based COVID-19 cases

A new study posted to the medRxiv* preprint server explores environmental surveillance of elementary school settings for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) through wastewater and surface samples monitoring. The researchers demonstrated that 93% of the COVID-19 cases in public elementary schools could be identified using this method.

25 Oct 2021

SARS-CoV-2 delta variant generates infections more quickly than previous strains

Researchers in the UK have conducted a study suggesting that the B.1.617.2 (delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – is transmitted more quickly than previously circulating variants.

25 Oct 2021

Virus News and Research

Latest Virus News and Research

A high-throughput pipeline for identifying nanobodies that target and neutralize SARS-CoV-2

Extending COVID-19 vaccinations to adolescents and children may lower the overall disease burden

HCV treatment decreases protein activity levels involved in liver cirrhosis, research shows

Hyperimmune antibody produced in horses may be an efficient approach to combat covid-19

Model suggests longer protection from SARS-CoV-2 neutralizing antibody response

Effectiveness of mRNA BNT162b2 COVID-19 vaccine in immunocompromised individuals

UQ researchers find that SARS-CoV-2 virus does not infect blood vessels

Attitudes towards COVID-19 vaccination amongst essential workers

Evaluation of COVID-19 infection risk during US spring semester in-person teaching

Identification of long COVID patients using big data

High and increasing SARS-CoV-2 infection prevalence amongst school-aged children in England

Sexually dimorphic placental antibody transfer during SARS-CoV-2 infection

Water and surface surveillance can detect 93% of school-based COVID-19 cases

SARS-CoV-2 delta variant generates infections more quickly than previous strains

COVID-19's impact on excess mortality in 2020 varied widely across Europe

Regulating blood insulin levels in obese, diabetic patients may help reduce COVID-19 risk

Can targeting autophagy become a new approach to COVID-19 treatment?

Researchers investigate SARS-CoV-2 specific immunity in young Swedish adults

Case Western Reserve secures $16 million to understand the relation between substance use and HIV

Deployment of UK's Emergency Medical Team in Papua New Guinea will help save lives

A new way of characterising biomolecules eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in